Comprehensive analysis of Navi ELSS Tax Saver Fund - Direct (G) (31604) providing detailed insights into fund performance, portfolio holdings, risk metrics, expense ratios, and investment recommendations.
Navi Trustee Limited
The Scheme will seek to invest predominantly in a diversified portfolio of equity and equity related instruments with the objective to provide investors with opportunities for capital appreciation and income generation along with the benefit of income tax deduction (under Section 80 C of the Income Tax Act, 1961) on their investments.
A comprehensive at-a-glance view of key mutual fund health indicatorsHover or click any card to view detailed metrics
Weak Returns
High Risk
Low Expense Ratio
Equity Focused
Experienced Team
Average Quality
Showing 1Y NAV history
Performance across different time periods
Fund shows mixed signals. Consider your investment timeline and risk tolerance.
Review detailed analysis and consider dollar-cost averaging through SIPs.
Fund shows mixed signals. Consider your investment timeline and risk tolerance.
Review detailed analysis and consider dollar-cost averaging through SIPs.
Fund manager experience
Market exposure level
Fund management costs
Outperformance vs benchmark
Historical performance consistency
Recent performance momentum
Risk-adjusted returns
Assets under management
This fund has underperformed its benchmark by 1.48% over the 3Y period.
See how your money can grow and compare with popular investment options
Disclaimer: Returns are illustrative and based on assumed rates. Mutual fund investments are subject to market risk. Please read scheme documents carefully.
| Company | Sector | % Assets |
|---|---|---|
| Reliance Industries Ltd | Refineries | 4.77% |
| Net CA & Others | Debt Others | 4.44% |
| Axis Bank Ltd | Banks | 3.86% |
| ICICI Bank Ltd | Banks | 3.73% |
| Bharti Airtel Ltd | Telecom-Service | 3.55% |
| UPL Ltd | Agro Chemicals | 3.52% |
| Sun Pharmaceutical Industries Ltd | Pharmaceuticals | 3.32% |
| HDFC Bank Ltd | Banks | 3.18% |
| State Bank of India | Banks | 3.10% |
| Aurobindo Pharma Ltd | Pharmaceuticals | 2.96% |
Compare against ELSS category average
This comparison shows how the fund performs relative to the ELSS category average. Positive values indicate outperformance, while negative values show underperformance.
Compare with similar funds in ELSS category
| Fund Name | NAV | 6M | 1Y | 3Y |
|---|---|---|---|---|
| Franklin India ELSS Tax Saver Fund - Direct (G) | ₹1672.09 | 12.57% | -2.82% | 19.25% |
| HDFC ELSS Tax Saver Fund - Direct (G) | ₹1575.49 | 15.64% | 2.75% | 22.32% |
| Franklin India ELSS Tax Saver Fund - Regular (G) | ₹1496.80 | 12.13% | -3.58% | 18.28% |
| HDFC ELSS Tax Saver Fund (G) | ₹1456.73 | 15.27% | 2.12% | 21.58% |
| ICICI Pru ELSS Tax Saver Fund - Direct (G) | ₹1066.44 | 16.49% | 0.40% | 16.98% |
| ICICI Pru ELSS Tax Saver Fund - (G) | ₹959.28 | 16.13% | -0.22% | 16.24% |
| Sundaram ELSS Tax Saver Fund - Direct (G) | ₹555.19 | 15.71% | 0.49% | 15.28% |
| Sundaram ELSS Tax Saver Fund - Direct (IDCW-H) | ₹554.62 | 15.71% | 0.49% | 15.27% |
| Sundaram ELSS Tax Saver Fund - Regular (G) | ₹518.69 | 15.41% | -0.04% | 14.65% |
| SBI ELSS Tax Saver Fund - Direct (G) | ₹478.67 | 12.50% | -2.79% | 24.35% |
A seasoned investment professional with over 10 years of experience in equity research and fund management. Known for consistent performance and a disciplined investment approach focused on quality growth stocks.